News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
80 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57662)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (24289)
Month
January (2882)
February (2030)
March (1769)
April (2200)
May (2664)
June (3161)
July (3087)
August (3800)
September (4259)
October (5135)
November (4629)
December (3503)
Day
1 (335)
2 (311)
3 (237)
4 (70)
6 (2)
7 (48)
8 (54)
9 (56)
10 (84)
11 (40)
13 (1)
14 (80)
15 (90)
16 (78)
17 (59)
18 (31)
20 (1)
21 (91)
22 (78)
23 (75)
24 (68)
25 (25)
26 (1)
28 (4)
29 (222)
30 (262)
31 (261)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
6
7
8
9
10
11
13
14
15
16
17
18
20
21
22
23
24
25
26
28
29
30
31
FDA
Immunicom’s Immunotherapy Product Receives U.S. FDA Breakthrough Device Designation for the Treatment of Cancer
Immunopheresis™ therapy is a proprietary technology that selectively removes immune inhibitors from a patient’s bloodstream potentially enabling their natural immune system to more-effectively attack cancer tumors.
May 14, 2018
·
3 min read
Deals
Surmodics Acquires Thrombectomy Technology Assets from Embolitech, Strengthening Peripheral Vascular Whole-Product Solutions Portfolio
Surmodics’ design, development, hydrophilic coating technology and manufacturing capabilities will advance innovative platform technology
May 14, 2018
·
4 min read
Drug Development
Concentric Analgesics Announces Positive Topline Results from Phase 1b Clinical Trial for CA-008 in Post-Surgical Pain
Clinically Meaningful Reductions in Pain Lasting for a Week
May 14, 2018
·
6 min read
Business
Complexa Appoints Francisco D. Salva Chief Executive Officer and President
Founder of Acerta Pharma to lead Complexa as it advances Phase 2 clinical development of lead compound CXA-10 in two orphan indications
May 14, 2018
·
3 min read
Bioasis Announces Private Placement and Intention to Pursue NASDAQ Listing
BIOASIS TECHNOLOGIES INC announce today a private placement of units (the “Units”) at a price of C$0.552 per Unit
May 14, 2018
·
7 min read
FDA
Baxter Announces U.S. FDA Clearance of New Spectrum IQ Infusion System
Designed with Exclusive New Features for Bi-Directional Electronic Medical Records Integration Including Auto-Programming and Auto-Documentation
May 14, 2018
·
6 min read
Deals
Agilent Completes Acquisition of Genohm
Acquisition enhances Agilent’s current software portfolio, adding LIMS and workflow management, while expanding ELN capability.
May 14, 2018
·
4 min read
VolitionRx Limited to Attend the Bank of America Merrill Lynch 2018 Health Care Conference from May 15-17, 2018
VolitionRx Limited (NYSE American: VNRX) (“Volition”) today announced its participation in the Bank of America Merrill Lynch 2018 Health Care Conference being held from May 15-17, 2018 at the Encore Hotel in Las Vegas, NV.
May 14, 2018
·
2 min read
FDA
Allium Medical Receives CFDA Clearance to Market its Minimally-invasive BPH Implant and Premium Urological Stents in China
The Company has a strategic agreement with a leading Urology distribution partner
May 14, 2018
·
2 min read
Policy
HedgePath Pharmaceuticals Announces Expanded Patent Coverage
HPPI’s patent portfolio expands with claims covering treatment of both hematologic and non-hematologic cancers with itraconazole, the active ingredient in HPPI’s current and anticipated future product candidates
May 14, 2018
·
5 min read
Previous
5 of 8
Next